In the largest study of its kind in any non-European population, an international team of researchers, including a University of
Read more
Home »
Immunotherapy effective in metastatic prostate cancers with specific markers of immune activation
Although metastatic castration-resistant prostate cancer (mCRPC) typically has limited response to immunotherapy, a subset of patients with pretreatment evidence of
Read more